Jens Peter Kroustrup
Overview
Explore the profile of Jens Peter Kroustrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ladebo L, Pedersen P, Pacyk G, Kroustrup J, Drewes A, Brock C, et al.
Obes Surg
. 2021 Mar;
31(6):2632-2640.
PMID: 33709293
Background: Studies investigating the underlying pathophysiology are needed to help explain and understand the postoperative complications following Roux-en-Y gastric bypass (RYGB) surgery. This study aimed to characterize segmental gastrointestinal pH...
2.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Clin Epidemiol
. 2019 Jan;
11:93-99.
PMID: 30666164
Background: The completeness of arranged during ransfection () testing in patients with medullary thyroid carcinoma (MTC) was recently reported as 60%. However, the completeness on a population level is unknown....
3.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Thyroid
. 2019 Jan;
29(3):368-377.
PMID: 30618340
Background: Survival of medullary thyroid carcinoma (MTC) subgroups in relation to the general population is poorly described. Data on the factors predicting long-term biochemical cure in MTC patients are nonexistent...
4.
Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study
Mathiesen J, Kroustrup J, Vestergaard P, Poulsen P, Rasmussen A, Feldt-Rasmussen U, et al.
Endocr Connect
. 2018 Dec;
8(1):1-7.
PMID: 30550378
A recent study proposed new TNM groupings for better survival discrimination among stage groups for medullary thyroid carcinoma (MTC) and validated these groupings in a population-based cohort in the United...
5.
Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Clin Epidemiol
. 2018 Oct;
10:1479-1487.
PMID: 30349395
Background: The incidence and prevalence of multiple endocrine neoplasia 2A (MEN2A) have only been reported once in a nationwide setting. However, it is unclear whether the figures are representative of...
6.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Endocr Connect
. 2018 May;
7(6):829-839.
PMID: 29760189
Recent studies have shown a significant increase in the temporal trend of medullary thyroid carcinoma (MTC) incidence. However, it remains unknown to which extent sporadic medullary thyroid carcinoma (SMTC) and...
7.
Founder Effect of the RET Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide Study
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Thyroid
. 2017 Oct;
27(12):1505-1510.
PMID: 29020875
Background: Multiple endocrine neoplasia (MEN) 2A and 2B are caused by REarranged during Transfection (RET) germline mutations. In a recent nationwide study, an unusually high prevalence (33%) of families with...
8.
Mathiesen J, Kroustrup J, Vestergaard P, Madsen M, Stochholm K, Poulsen P, et al.
Endocr Relat Cancer
. 2017 Apr;
24(7):L39-L42.
PMID: 28438782
No abstract available.
9.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Thyroid
. 2016 Nov;
27(2):215-223.
PMID: 27809725
Background: Germline mutations of the REarranged during Transfection (RET) proto-oncogene cause multiple endocrine neoplasia 2 (MEN2). It is unclear whether the distribution of RET mutations varies among populations. The first...
10.